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The death-factor Fas Ligand (FasL) is best known for its
capacity to induce cell death in Fas-expressing cells.
Besides its death-promoting activity, FasL has been impli-
cated in reverse signaling and might thus also play a role
in T cell development and selection and the modulation
of T cell activation by acting as a costimulatory receptor.
Here we have analyzed the influence of FasL-costimula-
tion on TCR/CD3/CD28-triggered activation of periph-
eral human T-lymphocytes. Interestingly, FasL
engagement inhibited the proliferation of PBMC, CD8+ as
well as CD4+ T cells. Plate-bound but not soluble FasFc
fusion protein or anti-FasL pAb blocked CD3/CD28-
induced proliferation almost completely. We observed
not only less proliferation, but also decreased IL-2 pro-
duction and reduced expression of the activation markers
CD69 and CD25. Importantly, FasFc costimulation also
resulted in a dramatic inhibition of TCR internalization,
thereby preventing TCR translocation and the formation
of signaling platforms essential for optimal T cell activa-
tion. Consistent with these findings, various crucial sign-
aling components of the T cell receptor activation
pathway were inhibited by FasL triggering and reverse sig-
nalling. In this context, the phosphorylation of ERK1/2,
p38 MAPK as well as further upstream acting signaling
proteins such as PLCγ was markedly reduced. Notably, the
inhibition was also observed in the presence of exogenous
rIL-2, indicating that a lack of IL-2 is not the cause of the
proliferation block. Taken together, our data argue for a
negative reverse signaling capacity of FasL on freshly iso-
lated, TCR-triggered human T cells.
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